Covid-19: UK first country to adopt antiviral drug

Last updated on November 6th, 2021 at 04:07 am

UK -The UK has approved using the anti-Covid pill Molnupiravir, manufactured by Merck & Co (MSD outside the United States and Canada) in partnership with Ridgeback Biotherapeutics. It is the first country to give the green light to the antiviral drug to treat Covid-19. MHRA, the UK drug agency, has authorized the pill to treat mild to moderate disease in adults who have tested positive for Coronavirus and have at least one risk factor for developing severe disease. It will be sold under the name of Lagevrio.

Molnupiravir is currently under review by other international regulatory bodies, such as the US FDA and the European EMA. The EMA said today those studies suggest that antiviral may reduce the ability of the Coronavirus to multiply in the body. Thus, preventing hospitalization or death in infected patients, and has been guaranteed to be ready to advise the Member States to make this new treatment available for emergency use before a marketing authorization.

Related Posts

Merck announced it expects to produce 10 million doses by the end of the year, pending possible authorizations from regulatory agencies, and at least 20 million in 2022. “Today is a historic day for our country (in the fight against the pandemic, ed) because the United Kingdom becomes the first country in the world to have approved an antiviral against Covid-19 that can be taken at home,” said Sajid Javid, a government minister of health of Boris Johnson. The agreement stipulated provides for the supply of the drug for 480,000 people in the United Kingdom.

Molnupiravir is an antiviral drug that in Phase 3 clinical study (performed on 775 patients) was shown to halve the risk of hospitalization and death in adult patients with mild and moderate Covid who were not vaccinated were at risk of developing severe disease. And 80% of the cases examined are of people infected with the variants (Delta, Gamma, and Mu). Thus, results that had been defined by the same immunologist Anthony Fauci, a consultant to the White House for the pandemic, were “impressive” and led to the suspension of the recruitment of volunteers for the superiority of the drug over placebo.

EU Reporter

As vast is the European region, the more diverse are the developments and news that are to be known. I bring to table the news and political affairs from region to your screens.

Recent Posts

Why the 2025 Flu Season in the UK Started Earlier Than Usual — and What It Means for Your H3N2 Vaccine Timing

The UK is experiencing a relatively early onset of the 2025 flu season, and this has caused anxiety in terms… Read More

December 6, 2025

K-Pop’s Influence on Global Sneakers: How Vans’ Fantasy Collabs Are Changing Fashion Trends

K-pop is not only ruling the world music charts, but the genre is also redefining the fashion trends from head… Read More

December 6, 2025

Rise of Digital Detox Cabins Across Europe: Why Screen-Free Retreats Are Becoming a Travel Trend

Due to the rise in the tech-driven nature of Europe, there is an increasing number of individuals yearning to get… Read More

December 6, 2025

IndiGo Flight-Cancellation Chaos in India: Impacts on Travel and Transport

Thousands of passengers have been stranded, and the impact of mass flight cancellations by IndiGo in India has brought extensive… Read More

December 6, 2025

U.S. Executive Action Against a Transnational Extremist Network Framed as a Global Security Priority

The recent U.S. Executive Order against a transnational extremist network is gaining a growing international movement that is backing the… Read More

December 6, 2025

Sustainable Weight Loss vs “Quick Fix” Meds: Routines, Food Habits, and Realistic Results

Sustainable weight loss is built on consistent habits, not miracle pills or overnight transformations. Instead of addressing the underlying causes… Read More

December 6, 2025

This website uses cookies.

Read More